Envestnet Asset Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Buy |
32,908
+10,671
| +48% | +$41.3K | ﹤0.01% | 4309 |
|
|
2025
Q1 | $111K | Buy |
+22,237
| New | +$111K | ﹤0.01% | 4222 |
|
|
2024
Q4 | – | Sell |
-19,084
| Closed | -$117K | – | 4301 |
|
|
2024
Q3 | $117K | Sell |
19,084
-8,732
| -31% | -$53.6K | ﹤0.01% | 4111 |
|
|
2024
Q2 | $185K | Sell |
27,816
-8,717
| -24% | -$58K | ﹤0.01% | 3953 |
|
|
2024
Q1 | $372K | Buy |
+36,533
| New | +$372K | ﹤0.01% | 3611 |
|
|
2023
Q3 | – | Sell |
-30,986
| Closed | -$109K | – | 4009 |
|
|
2023
Q2 | $109K | Buy |
30,986
+7,984
| +35% | +$28.2K | ﹤0.01% | 3823 |
|
|
2023
Q1 | $97.1K | Buy |
+23,002
| New | +$97.1K | ﹤0.01% | 3799 |
|
|
2021
Q4 | – | Sell |
-15,168
| Closed | -$172K | – | 3868 |
|
|
2021
Q3 | $172K | Buy |
+15,168
| New | +$172K | ﹤0.01% | 3528 |
|